Home
Subscription
January 2025 issue
BACK ISSUES
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2022 Issues
December 2022 Issue
• Feature: Christmas, Blessings, and Giving
• "O Holy Night"
• Appreciation
• Index for Volume 17, 2022
November 2022 Issue
• Feature: Paying $10 Billion Means Never Having to Say You are Sorry! No Accountability!
• Continued Deception and Arrogance of CVS
• Smoking – The Neglected Pandemic
• A Bipartisan Political Message
October 2022 Issue
• Feature: Rescuing Independent Pharmacy: Part 4 - The Inspiration of Independents
• Politics, Platforms, and Polls
September 2022 Issue
• Feature: Rescuing Independent Pharmacy: Part 3
August 2022 Issue
• Feature: Concepts and Strategies for Rescuing and Rebuilding Independent Pharmacy
July 2022 Issue
• Feature: Independence Day and Independents Day – THE FUTURE OF PHARMACY: THE SUICIDE OF OUR ONCE-NOBLE PROFESSION – UNLESS THERE IS A REVOLUTION!
June 2022 Issue
• Feature: The End of a Distinguished Era for the Philadelphia College of Pharmacy – And Best Wishes for Success in the Next Era!
• New Therapeutic Agents Marketed in the United States in 2021
May 2022 Issue
• Feature: Which is Stronger (Weaker) – AMA or APhA? It Doesn't Matter – They Need a Synergistic Working Relationship!
• Walgreens Passes CVS in a Metric on the Race to the Bottom!
• Paxlovid – A Blemished Success Story
April 2022 Issue
• Feature: LIVE and IN-PERSON
• Chain Lowlights
• Does Anyone Monitor the Regulators?
March 2022 Issue
• Feature: COVID-19 Vaccine Follies – Are There Really Any "Experts"?
• "CVS Ousts Executives After Probe"
• New Drug Review: Atogepant (Qulipta)
February 2022 Issue
• Feature: Medication Errors – If the Public Knew…
• Oral Antivirals for COVID-19 – We Must Learn from Experience
• New Drug Review: Nirmatrelvir/ritonavir (Paxlovid)
January 2022 Issue
• Feature: COVID-19 – Two Years Later
• Continued PBM Deception and Fraud
• New Drug Review: Aducanumab-avwa (Aduhelm)
| |
